Bastide le Confort Medical: management transactions · France · AMF

About Bastide le Confort Medical

Bastide Le Confort Médical is a leading French home healthcare provider and medical-device distributor listed on Euronext Paris under ISIN FR0000035370. The company was founded in 1977 in Nîmes by Guy Bastide, a pharmacist who built the business around a simple but powerful idea: patients should be able to receive high-quality care at home, with a level of support comparable to hospital-based treatment. That founding principle remains central to the group’s identity and long-term strategy. Originally focused on respiratory care, Bastide gradually broadened its service portfolio to become a comprehensive homecare platform. Today, the group operates across six core therapeutic areas: diabetes, nutrition, infusion, respiratory care, stoma care and urology, wound healing, and broader home support services. Its model combines medical devices, care protocols, monitoring, maintenance, and patient support, with an emphasis on continuity of care and close coordination with healthcare professionals. Bastide positions itself as a partner that helps improve patient comfort, autonomy, and quality of life. From a market standpoint, Bastide holds a strong position in France, particularly in respiratory homecare and device-based support services, where it is described by the company as one of the French leaders. The group has also built a broad territorial footprint through a network of agencies, integrated stores, and franchises. According to its latest disclosures, Bastide operates 110 franchises and 54 integrated stores in France, enabling it to combine local proximity with operational consistency. Internationally, the group reports a presence in 8 countries across 3 continents, reflecting a strategy of selective geographic expansion. Recent financial performance confirms the resilience of the model. In fiscal year 2024-2025, continuing operations generated revenue of €491.2 million, up 8% year on year, while recurring operating margin reached 9.0% and operating free cash flow amounted to €23.3 million. As of December 31, 2025, Bastide reported leverage of 2.77x, improving versus 3.41x at June 30, 2025, which underscores a steady deleveraging trend after portfolio simplification and asset disposals. On governance, Bastide Le Confort Médical is a French public limited company with a board of directors, led by Vincent Bastide. The group also highlights CSR as a core pillar of its corporate purpose, consistent with its exposure to structural healthcare needs driven by population aging, chronic diseases, and the expansion of care at home.